White paper on peanut allergy – part 1: Epidemiology, burden of disease, health economic aspects
Lars Lange(St. Marien-Hospital Bonn), Christian Vogelberg(University Hospital Carl Gustav Carus)
Cited by 34
Related Papers
Anaphylaxis in children and adolescents: The European Anaphylaxis Registry
|Journal of Allergy and Clinical Immunology|2016|598
Effect of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Ingestion Among Children With Peanut Allergy
|JAMA|2019|271
Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year results
|Journal of Allergy and Clinical Immunology|2020|101
Efficacy and Safety of Epicutaneous Immunotherapy in Peanut-Allergic Toddlers: Open-Label Extension to EPITOPE
|The Journal of Allergy and Clinical Immunology In Practice|2025|14